Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 7,777 | 7,805 | -4,402 | 5,770 | 6,232 |
| Operating Income | -7,777 | -7,805 | 2,754 | -5,770 | -6,232 |
| Interest Expense | 714 | 342 | 1,452 | 1,078 | 1,067 |
| Other Income | 932 | 118 | -773 | -350 | 0 |
| Pre-tax Income | -7,559 | -8,029 | 529 | -7,198 | -7,299 |
| Net Income Continuous | -7,559 | -8,029 | 529 | -7,198 | -7,299 |
| Net Income | $-7,559 | $-8,029 | $529 | $-7,198 | $-7,299 |
| EPS Basic Total Ops | -2.61 | -24.77 | -38.60 | -22.67 | -23.20 |
| EPS Basic Continuous Ops | -2.61 | -24.77 | -38.71 | -22.64 | -23.17 |
| EPS Diluted Total Ops | -2.61 | -24.77 | -38.60 | -22.67 | -23.20 |
| EPS Diluted Continuous Ops | -2.61 | -24.77 | -38.71 | -22.64 | -23.17 |
| EBITDA(a) | $-7,276 | $-7,695 | $4,696 | $-5,476 | $-5,991 |